Ben Ferrari
Geen lopende functies
Loopbaan van Ben Ferrari
Eerdere bekende functies van Ben Ferrari
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Imprimatur Capital Ltd.
 Imprimatur Capital Ltd. Investment ManagersFinance Imprimatur Capital Ltd. (Imprimatur Capital) is a venture capital firm founded in 2003 by Ian Watson. The firm is headquartered in London with additional office in Singapore. | Algemeen Directeur | 21-06-2011 | 01-01-2012 |
| Corporate Officer/Principal | 25-11-2009 | 21-06-2011 | |
| University of Surrey | Corporate Officer/Principal | - | - |
| University of St. Andrews | Hoofd Techniek/Wetenschap/O&O | - | - |
| Royal Holloway University of London | Corporate Officer/Principal | - | - |
| Surrey, Inc. | Directeur/Bestuurslid | - | - |
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Directeur/Bestuurslid | 25-11-2009 | - |
| Independent Dir/Board Member | 21-06-2011 | - |
Statistieken
Internationaal
| Verenigd Koninkrijk | 6 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Services | 2 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Evgen Ltd.
Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Health Services |
Imprimatur Capital Ltd.
Imprimatur Capital Ltd. Investment ManagersFinance Imprimatur Capital Ltd. (Imprimatur Capital) is a venture capital firm founded in 2003 by Ian Watson. The firm is headquartered in London with additional office in Singapore. | Finance |
| Surrey, Inc. | Consumer Non-Durables |
- Beurs
- Insiders
- Ben Ferrari
- Ervaring
